English

Dongsheng Pharmaceutical International Co., Ltd.

EDGAR

Quarterly report (10-Q) · filed 2011-05-20

9 filing records in this dataset, filed from 2009-05-11 to 2011-05-20. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.7 million USD

2011-03-31 · USD

Exact inputs and evidence

Revenue: 1698633 USD Source

Operating margin

-10.39%

2011-03-31 · %

Exact inputs and evidence

Operating Income: -176485 USD Source
Revenue: 1698633 USD Source

Operating cash flow

805 thousand USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1187432 USD Source
Operating Cash Flow: -1992072 USD Source

Free cash flow

805 thousand USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1187432 USD Source
Operating Cash Flow: -1992072 USD Source
Capital Expenditure: 503 USD Source
Capital Expenditure: 499 USD Source

Cash and cash equivalents: 159 thousand USD 2011-03-31 Source
Exact value

159387 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.2 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Revenue: 20479212 USD · 2009-07-01 – 2010-06-30 Source
Revenue: 12024838 USD · 2009-07-01 – 2010-03-31 Source
Revenue: 3935356 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 4134443 USD · 2010-10-01 – 2010-12-31 Source
Revenue: 1698633 USD · 2011-01-01 – 2011-03-31 Source

Net income

1.48 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Net income: 4057487 USD · 2009-07-01 – 2010-06-30 Source
Net income: 3131342 USD · 2009-07-01 – 2010-03-31 Source
Net income: 437654 USD · 2010-07-01 – 2010-09-30 Source
Net income: 241550 USD · 2010-10-01 – 2010-12-31 Source
Net income: -122173 USD · 2011-01-01 – 2011-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-05-20.

Financial data available through: 2010-06-30.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2010-06-30
Operating income: 2 of 11 periods available· newest 2010-06-30
Net income: 3 of 11 periods available· newest 2010-06-30
Operating cash flow: 3 of 11 periods available· newest 2010-06-30
Capital expenditure: 2 of 11 periods available· newest 2010-06-30
Total assets: 3 of 11 periods available· newest 2010-06-30
Total liabilities: 3 of 11 periods available· newest 2010-06-30
Current assets: 3 of 11 periods available· newest 2010-06-30
Current liabilities: 3 of 11 periods available· newest 2010-06-30
Cash and cash equivalents: 3 of 11 periods available· newest 2010-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.6%

Prior period

USD 17.13 million

2008-07-01 – 2009-06-30
Current period

USD 20.48 million

2009-07-01 – 2010-06-30

Exact inputs and evidence

20479212 − 17127474 = 3351738 USD

17127474 USD · 2008-07-01 – 2009-06-30
Inspect prior input Prior source
20479212 USD · 2009-07-01 – 2010-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Year-over-year change in Revenue: 3351738 USD Concept: fundies:Revenue Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 20479212 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4146 Input fundies:Revenue: 17127474 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4146
The citation records this snapshot. The page link may show a newer release later.
Net income
+69.7%

Prior period

USD 2.39 million

2008-07-01 – 2009-06-30
Current period

USD 4.06 million

2009-07-01 – 2010-06-30

Exact inputs and evidence

4057487 − 2391595 = 1665892 USD

2391595 USD · 2008-07-01 – 2009-06-30
Inspect prior input Prior source
4057487 USD · 2009-07-01 – 2010-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Year-over-year change in Net income: 1665892 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 4057487 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4987 Input fundies:NetIncome: 2391595 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4987
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-58%

Prior period

USD 2.96 million

2008-07-01 – 2009-06-30
Current period

USD 1.24 million

2009-07-01 – 2010-06-30

Exact inputs and evidence

1242671 − 2957297 = -1714626 USD

2957297 USD · 2008-07-01 – 2009-06-30
Inspect prior input Prior source
1242671 USD · 2009-07-01 – 2010-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Year-over-year change in Operating cash flow: -1714626 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1242671 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203 Input fundies:OperatingCashFlow: 2957297 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-56.6%

Prior period

USD 77,883

2008-07-01 – 2009-06-30
Current period

USD 33,805

2009-07-01 – 2010-06-30

Exact inputs and evidence

33805 − 77883 = -44078 USD

77883 USD · 2008-07-01 – 2009-06-30
Inspect prior input Prior source
33805 USD · 2009-07-01 – 2010-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Year-over-year change in Capital expenditure: -44078 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 33805 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227 Input fundies:CapitalExpenditure: 77883 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-07-01 – 2010-06-30

Revenue USD 20.48 million 100% of revenue
Operating costs Derived USD 14.97 million 73% of revenue
Operating income USD 5.51 million 27% of revenue
Tax, interest and other Derived USD 1.45 million 7.1% of revenue
Net income USD 4.06 million 20% of revenue

Cash

Operating cash flow USD 1.24 million 6.1% of revenue
Capital expenditure USD 33,805 0.2% of revenue
Free cash flow Derived USD 1.21 million 5.9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 14%81%
2009 Not shown: operating income or net income is not reported.
2010 20%73%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2008-07-01 – 2009-06-30	17127474	13925986 Derived	3201488	809893 Derived	2391595	2879414 Derived	Source 2008-07-01 – 2009-06-30: 17127474 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: 3201488 USD Inspect Operating Income Open source 2008-07-01 – 2009-06-30: 2391595 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: 2957297 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 77883 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	0	Unavailable	Unavailable	Unavailable	-33259	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -33259 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -30984 USD Inspect Operating Cash Flow Open source
2010 2009-07-01 – 2010-06-30	20479212	14968097 Derived	5511115	1453628 Derived	4057487	1208866 Derived	Source 2009-07-01 – 2010-06-30: 20479212 USD Inspect Revenue Open source 2009-07-01 – 2010-06-30: 5511115 USD Inspect Operating Income Open source 2009-07-01 – 2010-06-30: 4057487 USD Inspect Net Income Open source 2009-07-01 – 2010-06-30: 1242671 USD Inspect Operating Cash Flow Open source 2009-07-01 – 2010-06-30: 33805 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 20.5M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Revenue	17127474	Revenue: 17127474 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-06-30	Revenue	20479212	Revenue: 20479212 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.6% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Year over year	No prior comparable period	Revenue: 17127474 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20102010-06-30	Year over year	19.6%	Revenue: 20479212 Open source Revenue: 17127474 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 26.9% 2010

Net margin 19.8% 2010

Free cash flow margin 5.9% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Operating margin	18.7%	Operating Income: 3201488 Open source Revenue: 17127474 Open source
2009-12-31	Operating margin	Not reported	Revenue: 0 Open source
20102010-06-30	Operating margin	26.9%	Operating Income: 5511115 Open source Revenue: 20479212 Open source
20092009-06-30	Net margin	14%	Net Income: 2391595 Open source Revenue: 17127474 Open source
20092009-12-31	Net margin	Not reported	Net Income: -33259 Open source Revenue: 0 Open source
20102010-06-30	Net margin	19.8%	Net Income: 4057487 Open source Revenue: 20479212 Open source
20092009-06-30	Free cash flow margin	16.8%	Revenue: 17127474 Open source Operating Cash Flow: 2957297 Open source Capital Expenditure: 77883 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -30984 Open source
20102010-06-30	Free cash flow margin	5.9%	Revenue: 20479212 Open source Operating Cash Flow: 1242671 Open source Capital Expenditure: 33805 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.2M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Operating cash flow	2957297	Operating Cash Flow: 2957297 Open source
20092009-12-31	Operating cash flow	-30984	Operating Cash Flow: -30984 Open source
20102010-06-30	Operating cash flow	1242671	Operating Cash Flow: 1242671 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.2M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Free cash flow	2879414	Operating Cash Flow: 2957297 Open source Capital Expenditure: 77883 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -30984 Open source
20102010-06-30	Free cash flow	1208866	Operating Cash Flow: 1242671 Open source Capital Expenditure: 33805 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

26.5% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Liabilities / assets	96.7%	Total Liabilities: 9557623 Open source Total Assets: 9884271 Open source
20092009-12-31	Liabilities / assets	264.6%	Total Liabilities: 3525 Open source Total Assets: 1332 Open source
20102010-06-30	Liabilities / assets	26.5%	Total Liabilities: 1589503 Open source Total Assets: 6003622 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.45× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Current assets / current liabilities	0.62×	Current Assets: 5851561 Open source Current Liabilities: 9471424 Open source
20092009-12-31	Current assets / current liabilities	0.38×	Current Assets: 1332 Open source Current Liabilities: 3525 Open source
20102010-06-30	Current assets / current liabilities	3.45×	Current Assets: 5478073 Open source Current Liabilities: 1589503 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2008-07-01 – 2009-06-30	USD 2.39 million Exact value Exact value: 2391595 USD 2008-07-01 – 2009-06-30: 2391595 USD Inspect Net Income Open source Share or cite Citation for Net Income · Dongsheng Pharmaceutical International Co., Ltd. · 2009-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Net Income: 2391595 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: 2391595 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4987 The citation records this snapshot. The page link may show a newer release later.	USD 2.96 million Exact value Exact value: 2957297 USD 2008-07-01 – 2009-06-30: 2957297 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Dongsheng Pharmaceutical International Co., Ltd. · 2009-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Operating Cash Flow: 2957297 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2957297 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203 The citation records this snapshot. The page link may show a newer release later.	USD 77,883 Exact value Exact value: 77883 USD 2008-07-01 – 2009-06-30: 77883 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Dongsheng Pharmaceutical International Co., Ltd. · 2009-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Capital Expenditure: 77883 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 77883 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227 The citation records this snapshot. The page link may show a newer release later.	USD 2.88 million Calculation and evidence 2957297 − 77883 USD Exact free cash flow: 2879414 USD 2008-07-01 – 2009-06-30: 2957297 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 77883 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Dongsheng Pharmaceutical International Co., Ltd. · 2009-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Free cash flow: 2879414 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2957297 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203 Input fundies:CapitalExpenditure: 77883 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 33,259 Exact value Exact value: -33259 USD 2009-01-01 – 2009-12-31: -33259 USD Inspect Net Income Open source Share or cite Citation for Net Income · Dongsheng Pharmaceutical International Co., Ltd. · 2009-12-31 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Net Income: -33259 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33259 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-000369.txt#3824 The citation records this snapshot. The page link may show a newer release later.	−USD 30,984 Exact value Exact value: -30984 USD 2009-01-01 – 2009-12-31: -30984 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Dongsheng Pharmaceutical International Co., Ltd. · 2009-12-31 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Operating Cash Flow: -30984 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30984 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-000369.txt#3954 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-07-01 – 2010-06-30	USD 4.06 million Exact value Exact value: 4057487 USD 2009-07-01 – 2010-06-30: 4057487 USD Inspect Net Income Open source Share or cite Citation for Net Income · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Net Income: 4057487 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: 4057487 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#4987 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Exact value Exact value: 1242671 USD 2009-07-01 – 2010-06-30: 1242671 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Operating Cash Flow: 1242671 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1242671 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203 The citation records this snapshot. The page link may show a newer release later.	USD 33,805 Exact value Exact value: 33805 USD 2009-07-01 – 2010-06-30: 33805 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Capital Expenditure: 33805 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855/explain?concept=fundies%3ACapitalExpenditure&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33805 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Calculation and evidence 1242671 − 33805 USD Exact free cash flow: 1208866 USD 2009-07-01 – 2010-06-30: 1242671 USD · Inspect Operating Cash Flow · Source 2009-07-01 – 2010-06-30: 33805 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Dongsheng Pharmaceutical International Co., Ltd. · 2010-06-30 Dongsheng Pharmaceutical International Co., Ltd. (edgar:1444855) Free cash flow: 1208866 USD Concept: free-cash-flow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T16:21:16Z Snapshot: 787e8b32305f60e959e9c0e6f4d301757168918d26a7a36ec8758809cff4a7c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444855?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1242671 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5203 Input fundies:CapitalExpenditure: 33805 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444855/0001213900-10-003869.txt#5227 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

9 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001444855, 1444855, edgar:1444855

Also known as INDESTRUCTIBLE 1, INC

Dongsheng Pharmaceutical International Co., Ltd.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2009-07-01 – 2010-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation